Dendritic cells are specialized accessory cells along with TGF-β for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3- precursors

Blood

Volumn 110, Issue 13, 2007, Pages 4293-4302

  Yamazaki, Sayuri ^a   Bonito, Anthony J ^a   Spisek, Radek ^a   Dhodapkar, Madhav ^a   Inaba, Kayo ^b   Steinman, Ralph M ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 2; L SELECTIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN; TUMOR IMMUNOLOGY; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; HEMATOPOIETIC STEM CELL; IMMUNITY; IMMUNOLOGY; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; ANTIGENS; CELL DIFFERENTIATION; DENDRITIC CELLS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HEMATOPOIETIC STEM CELLS; IMMUNITY; MICE; MICE, KNOCKOUT; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTORS;

EID: 39549099367     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-05-088831     Document Type: Article

References (80)

1. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 1998;8:275-283.
2. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature. 1996;383:787-793.
3. Wynn TA. Fibrotic disease and the TH1/TH2 paradigm. Nat Rev Immunol. 2004;4:583-594.
4. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity. 2004;21:467-476.
5. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity. 2006;24:677-688.
6. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor foxp3. Science. 2003;299:1057-1061.
7. + regulatory T cells. Nat Immunol. 2003;4:330-336.
8. + T regulatory cells. Nat Immunol. 2003;4:337-342.
9. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997;389:737-742.
10. + Tr cells. Blood. 2005;105:1162-1169.
11. Berenson LS, Ota N, Murphy KM. Issues in Thelper 1 development-resolved and unresolved. Immunol Rev. 2004;202:157-174.
12. + T cells from T cell receptor transgenic mice. J Exp Med. 1992;176:1091-1098.
13. Soumelis V, Reche PA, Kanzler H, et al. Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP. Nat Immunol. 2002;3:673-680.
14. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235-238.
15. Mangan PR, Harrington LE, O'Quinn DB, et al. Transforming growth factor-β induces development of the T(H)17 lineage. Nature. 2006;441:231-234.
16. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006;24:179-189.
17. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med. 2003;198:1875-1886.
18. - T cells through Foxp3 induction and down-regulation of Smad7. J Immunol. 2004;172:5149-5153.
19. + T cells. Int Immunol. 2004;16:1203-1213.
20. + regulatory cells. J Immunol. 2006;176:3321-3329.
21. Weber SE, Harbertson J, Godebu E, et al. Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo. J Immunol. 2006;176:4730-4739.
22. Pulendran B, Smith JL, Caspary G, et al. Distinct dendritic cell subsets differentially regulate the class of immune responses in vivo. Proc Natl Acad Sci USA. 1999;96:1036-1041.
23. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med. 1999;189:587-592.
24. MacDonald AS, Straw AD, Dalton NM, Pearce EJ. Th2 response induction by dendritic cells: a role for CD40. J Immunol. 2002;168:537-540.
25. H-17 cells in relapsing EAE. Nat Immunol. 2007;8:172-180.
26. Dhodapkar MV, Steinman RM, Krasovsky J, Münz C, Bhardwaj N. Antigen specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med. 2001;193:233-238.
27. + regulatory T cells. Proc Natl Acad Sci U S A. 2007;104:2821-2826.
28. Kim JM, Rudensky A. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol Rev. 2006;212:86-98.
29. Shevach EM. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity. 2006;25:195-201.
30. +TCRlo thymocytes in vivo. Science. 1990;250:1720-1723.
31. Wan YY, Flavell RA. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci U S A. 2005;102:5126-5131.
32. + regulatory T cells by antigen processing dendritic cells. J Exp Med. 2003;198:235-247.
33. Saff RR, Spanjaard ES, Hohlbaum AM, Marshak-Rothstein A. Activation-induced cell death limits effector function of CD4 tumor-specific T cells. J Immunol. 2004;172:6598-6606.
34. Hawiger D, Inaba K, Dorsett Y, et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med. 2001;194:769-780.
35. Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a co-administered protein. J Exp Med. 2003;198:267-279.
36. + T cell tolerance through PD-1 and CTLA-4. Nat Immunol. 2005;6:280-286.
37. Monteleone G, Pallone F, MacDonald TT. Smad7 in TGF-β-mediated negative regulation of gut inflammation. Trends Immunol. 2004;25:513-517.
38. + regulatory T cell function. J Exp Med. 2002;196:851-857.
39. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med. 2005;201:723-735.
40. + T regulatory cell development during the neonatal period. J Exp Med. 2005;201:769-777.
41. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol. 2005;6:1142-1151.
42. + regulatory T cells and for expansion of these cells. J Immunol. 2007;178:2018-2027.
43. + T regulatory cells. J Immunol. 2007;178:4022-4026.
44. Granucci F, Vizzardelli C, Pavelka N, et al. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol. 2001;2:882-888.
45. Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol. 2002;2:116-126.
46. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol. 2005;6:1219-1227.
47. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2000;192:303-310.
48. + regulatory cells that control intestinal inflammation. J Exp Med. 2000;192:295-302.
49. + immunoregulatory T cells that control autoimmune diabetes. Immun. 2000;12:431-440.
50. + regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol. 2002;3:135-142.
51. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immun. 2002;16:311-323.
52. + T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulaton. Int Immunol. 2000;12:1145-1155.
53. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J Immunol. 2002;169:2461-2465.
54. + T reg cells. J Exp Med. 2006;203:1701-1711.
55. Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med. 2006;203:1693-1700.
56. + regulatory T cells. Proc Natl Acad Sci U S A. 2002;99:13031-13066.
57. + regulatory T cells. J Exp Med. 2004;199:303-313.
58. Lim SP, Leung E, Krissansen GW. The β7 integrin gene (Itgb-7) promoter is responsive to TGF-β1: defining control regions. Immunogenetics. 1998;48:184-195.
59. reg and control of Leishmania major infection. J Immunol. 2005;174:5444-5455.
60. Annacker O, Coombes JL, Malmstrom V, et al. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J Exp Med. 2005;202:1051-1061.
61. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531-562.
62. + suppressor T cells: more questions than answers. Nat Rev Immunol. 2002;2:389-400.
63. Bluestone JA. Regulatory T-cell therapy: is it ready for the clinic? Nat Rev Immunol. 2005;5:343-349.
64. + regulatory cell activation and function by dendritic cells. Int Immunol. 2004;16:1769-1780.
65. + T cells without reversing their suppressive function. J Immunol. 2005;175:7332-7340.
66. high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients. Blood. 2006;108:2655-2661.
67. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med. 2004;199:1467-1477.
68. + regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med. 2007;204:191-201.
69. - regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc Natl Acad Sci U S A. 2006;103:2758-2763.
70. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immun. 2005;22:329-341.
71. + regulatory T cells in vivo requires B7 costimulation, but not the thymus. J Exp Med. 2005;201:127-137.
72. + T lymphocytes into memory and/or effector cells in vivo. Eur J Immunol. 2004;34:1861-1869.
73. + lymphocytes as compared with nonprofessional APC. J Immunol. 2001;167:1188-1197.
74. Steinman RM, Nussenzweig MC. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A. 2002;99:351-358.
75. + regulatory T cell proliferation. J Exp Med. 2005;202:919-929.
76. Morelli AE, Zahorchak AF, Larregina AT, et al. Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation. Blood. 2001;98:1512-1523.
77. H17 and regulatory T cell differentiation mediated by retinoic acid. Science. 2007;317:256-260.
78. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med. 2007;204:1765-1774.
79. + regulatory T cells via a TGF-β- and retinoic acid-dependent mechanism. J Exp Med. 2007;204:1757-1764.
80. Sun CM, Hall JA, Blank RB, et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med. 2007;204:1775-1785.